Piper Sandler Maintains Overweight on DexCom, Raises Price Target to $120

Piper Sandler analyst Matt O'Brien maintains DexCom (NASDAQ:DXCM) with a Overweight and raises the price target from $110 to $120.

byBenzinga Newsdesk

October 7, 2022

1 minute read

Piper Sandler analyst Matt O’Brien maintains DexCom (NASDAQ:DXCM) with a Overweight and raises the price target from $110 to $120.

National Bank Bumps Up Trican Well Service Price Target By 56%

By Akanksha Bakshi

Today, 5:16 AM

Trican Well Service Ltd (TSX:TCW) (OTC:TOLWF) has been upgraded to Outperform from Sector Perform, and the price target was raised…

TOLWF

Delta Air Lines To Rally Around 84%? Here Are 5 Other Price Target Changes For Tuesday

By Lisa Levin

Today, 5:16 AM

Raymond James raised Delta Air Lines, Inc. (NYSE: DAL) price target from $50 to $52. Raymond James analyst Savanthi Syth maintained a Strong Buy rating on the stock. Delta Air shares rose 0.7% to close at $28.26 on Monday.

ACCD

Barclays Initiates Coverage On Vonage Hldgs with Overweight Rating, Announces Price Target of $20

By Benzinga Newsdesk

Today, 5:16 AM

Barclays analyst Ryan Macwilliams initiates coverage on Vonage Hldgs (NASDAQ:VG) with a Overweight rating and announces Price Target of $20.

Read How Analysts Reacted To GameStop’s Q3 Results

By Anusuya Lahiri

Today, 5:16 AM

As management lays the groundwork to transform GameStop Corp (NYSE:GME) into a “technology” company, “many details still remain a mystery,” Baird analyst…

AMZN

Piper Sandler Maintains Overweight on DexCom, Raises Price Target to $120

Related Posts

National Bank Bumps Up Trican Well Service Price Target By 56%

Delta Air Lines To Rally Around 84%? Here Are 5 Other Price Target Changes For Tuesday

Barclays Initiates Coverage On Vonage Hldgs with Overweight Rating, Announces Price Target of $20

Read How Analysts Reacted To GameStop’s Q3 Results